Clinical trials
Post-Acute COVID-19 Syndrome trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 14 |
| 2023 | 22 |
| 2024 | 22 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 19 |
| Active, not recruiting | 7 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VA Office of Research and Development | 7 |
| Icahn School of Medicine at Mount Sinai | 6 |
| Duke University | 5 |
| Columbia University | 3 |
| Mayo Clinic | 3 |
| University of California, Los Angeles | 3 |
| University of Colorado, Denver | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Massachusetts General Hospital | 2 |
| University of California, Davis | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post-Acute COVID-19 Syndrome | 78 |
| COVID-19 | 19 |
| Fatigue | 9 |
| Cognitive Dysfunction | 8 |
| Fatigue Syndrome, Chronic | 7 |
| Mental Fatigue | 7 |
| Dyspnea | 4 |
| Anxiety Disorders | 3 |
| Autonomic Nervous System Diseases | 3 |
| Postural Orthostatic Tachycardia Syndrome | 3 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.